COMPARATIVE CLINICAL AND ECONOMIC ANALYSIS OF THE INTENSIFICATION THERAPY IN PATIENTS WITH UNCONTROLLED DIABETES TYPE 2 USING BASAL INSULIN OR DAPAGLIFLOZIN

• Glavni autori: V. I. Petrov (Autor), S. V. Nedogoda (Autor), M. Yu. Frolov (Autor), A. S. Salasyuk (Autor), I. N. Barykina (Autor), V. O. Smirnova (Autor), V. Yu. Khripaeva (Autor)
• Format: Knjiga
• Izdano: IRBIS LLC, 2016-04-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Objective. Determine if dapagliflozin use is pharmacoeconomically reasonable option for patients with inadequate glycemic control compared with basal insulin.Materials and Methods. The study was conducted according to standard pharmacoeconomic methods: cost-utility analysis (CUA), budget impact anal...